Zacks.com on MSN1h
Pharma Stock Roundup: FDA Updates for JNJ, GSK, PFE, NVO's Expanded DealThis week, the FDA granted priority review status to J&J’s JNJ application seeking approval of key pipeline candidate ...
A new weight loss biotech launched with $410 million and three assets from China. Roche's Chugai penned a deal to develop ...
A two-drug combination extended OS compared with standard first-line osimertinib for certain patients with advanced lung ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback